Design and rationale for a global novel non-invasive screening observational study using genetics and non-invasive methodologies to identify at-risk MASLD participants: The ALIGN study

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver disease that is heterogenous in nature with various drivers and modifiers such as metabolic dysfunction and genetic factors. MASLD and the progressive subtype, metabolic dysfunction-associated steatohepatitis...

Full description

Saved in:
Bibliographic Details
Main Authors: Samuel J. Daniels, Karin Nelander, John Eriksson, Lutz Jermutus, Jelena Saillard, Stephanie Oyesola, Federica Tavaglione, Marco Arrese, Alma Laura Ladrón de Guevara, Umberto Vespasiani-Gentilucci, Naim Alkhouri, Jenny E. Blau
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Contemporary Clinical Trials Communications
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865425000110
Tags: Add Tag
No Tags, Be the first to tag this record!